Abstract
Faculty Opinions recommendation of Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have